Skip to Main Content

Author Details

Tobias Weiss
Westlake University
2009
50
18
PMIDPaper TitleJournal TitlePublished Year
36702828Author Correction: Federated learning enables big data for rare cancer boundary detection.Nat Commun2023
37609137Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability.bioRxiv2023
37925634Protocol for the expansion of mouse immune effector cells for in vitro and in vivo studies.STAR Protoc2023
35802605Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.Neuro Oncol2023
37467314Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.Sci Transl Med2023
37335916Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.Neuro Oncol2023
37368072A T-cell antigen atlas for meningioma: novel options for immunotherapy.Acta Neuropathol2023
37224228Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma.Sci Transl Med2023
36915128Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition.Acta Neuropathol Commun2023
36839699An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties.Pharmaceutics2023
35323193Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21.Antibodies (Basel)2022
35608370Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Macrocycles.J Med Chem2022
36470898Federated learning enables big data for rare cancer boundary detection.Nat Commun2022
36419823RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug.Oncoimmunology2022
36178522The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.Acta Neuropathol2022
36104101Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody.J Immunother Cancer2022
36037304Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma.Clin Cancer Res2022
36228153Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma.Clin Cancer Res2022
35177622T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.Nat Commun2022
35174975A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.EMBO Mol Med2022
33471197Endoglin and TGF-β signaling in glioblastoma.Cell Tissue Res2021
33654311Pathway-based stratification of glioblastoma.Nat Rev Neurol2021
33772427A tumor-promoting role for soluble TβRIII in glioblastoma.Mol Cell Biochem2021
34878820Slow-wave sleep affects synucleinopathy and regulates proteostatic processes in mouse models of Parkinson's disease.Sci Transl Med2021
34079902Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression.ACS Cent Sci2021
34000060Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).Swiss Med Wkly2021
32398144Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee.BMC Cancer2020
33339831Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype.Nat Commun2020
33028706Immunocytokines are a promising immunotherapeutic approach against glioblastoma.Sci Transl Med2020
33053341Neutrophils Obstructing Brain Capillaries Are a Major Cause of No-Reflow in Ischemic Stroke.Cell Rep2020
33136526Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors <i>in vivo</i>.MAbs2020
33239441An engineered 4-1BBL fusion protein with "activity on demand".Proc Natl Acad Sci U S A2020
30949747Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies.Neuroradiology2019
31386047Complementary and alternative medicine use by glioma patients in Switzerland.Neurooncol Pract2019
31495056High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.Mol Oncol2019
29162646NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma.Clin Cancer Res2018
30084848A tissue-based draft map of the murine MHC class I immunopeptidome.Sci Data2018
29679127[Basic principles of diagnosis and treatment of gliomas].Nervenarzt2018
29480969Transcriptional control of O<sup>6</sup> -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma.J Neurochem2018
29222400NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.Cancer Res2018
29221966Lesion magnetic susceptibility response to hyperoxic challenge: A biomarker for malignant brain tumor microenvironment?Magn Reson Imaging2018
29238047Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.Cell Death Dis2017
28355572Precise Temporal Profiling of Signaling Complexes in Primary Cells Using SWATH Mass Spectrometry.Cell Rep2017
27354956Non-parametric intravoxel incoherent motion analysis in patients with intracranial lesions: Test-retest reliability and correlation with arterial spin labeling.Neuroimage Clin2016
27598516Immunological effects of chemotherapy and radiotherapy against brain tumors.Expert Rev Anticancer Ther2016
26402401Immunotherapy for glioblastoma: concepts and challenges.Curr Opin Neurol2015
24862539Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.Acta Oncol2014
23161203Gamma-hydroxybutyrate (GHB) and topiramate--clinically relevant drug interaction suggested by a case of coma and increased plasma GHB concentration.Eur J Clin Pharmacol2013
19276185Claudin-7 regulates EpCAM-mediated functions in tumor progression.Mol Cancer Res2009
19483654The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction.J Immunother2009
  • 1 - 50 of 50

Recommended Authors

Olivia Singh
Princess Margaret Cancer Centre
Career Start Year 2016
Number of shared co-authors 5
Malaka Ameratunga
Australia Central Clinical School, Monash University
Career Start Year 2014
Number of shared co-authors 1
Maxim Sidorov
California Pacific Medical Center Research Institute
Career Start Year 2009
Number of shared co-authors 0
Adam M Sonabend
Northwestern University
Career Start Year 2005
Number of shared co-authors 4
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Verlene Henry
The MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Nicholas Butowski
University of California san francisco
Career Start Year 2005
Number of shared co-authors 10
Catherine P Langford
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 0
Jun Wei
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Gavin P Dunn
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 9
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 10
Johanna Buchroithner
Johannes Kepler University
Career Start Year 2001
Number of shared co-authors 10
Marta M Alonso
CIMA-Universidad de Navarra
Career Start Year 2001
Number of shared co-authors 14
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 17
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 8
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 12
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 7
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 12
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 16
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 12
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 5
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 20
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 5
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Career Start Year 1988
Number of shared co-authors 6
Camilo E Fadul
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 0
Kenneth Aldape
National Cancer Institute
Career Start Year 1985
Number of shared co-authors 32
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 4
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 19
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 11
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 13

Collaborators

Michael Weller
University Hospital and University of Zurich
Co-authored papers 39
Ruedi Aebersold
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 4
Elisabeth J Rushing
Co-authored papers 4
Benedikt Wiestler
Technical University
Co-authored papers 4
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Guido Reifenberger
Heinrich Heine University
Co-authored papers 3
Alex Look
Dana-Farber Cancer Institute
Co-authored papers 3
Christos Davatzikos
University of Pennsylvania
Co-authored papers 2
Javier E Villanueva-Meyer
University of California san francisco
Co-authored papers 2
Farouk Dako
Center for Global Health, Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Tiannan Guo
Westlake University
Co-authored papers 2
Lola B Chambless
Vanderbilt University School of Medicine
Co-authored papers 2
Akshitkumar M Mistry
University of Louisville
Co-authored papers 2
Daniel S Marcus
Mallinckrodt Institute of Radiology, Washington University School of Medicine
Co-authored papers 2
Qi Dou
The Chinese University of Hong Kong
Co-authored papers 2
Evan Calabrese
University of California San Francisco
Co-authored papers 2
Joshua D Palmer
Co-authored papers 2
Ben Glocker
Imperial College London
Co-authored papers 2
Rivka R Colen
Co-authored papers 2
Benjamin M Ellingson
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 2
Jill S Barnholtz-Sloan
National Cancer Institute
Co-authored papers 2
Jeffrey D Rudie
Center for Intelligent Imaging (ci2), University of California san francisco
Co-authored papers 2
Nazanin Tatari
McMaster University
Co-authored papers 2
Joel Saltz
Stony Brook University
Co-authored papers 2
Rohan Bareja
Case Western Reserve University
Co-authored papers 2
Michael A Vogelbaum
Moffit Cancer Center
Co-authored papers 2
Adam E Flanders
Thomas Jefferson University
Co-authored papers 2
Pim J French
Erasmus MC Cancer Institute
Co-authored papers 2
Bjoern H Menze
Technische Universitat Munchen, University of Zurich
Co-authored papers 2
Raymond Y Huang
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 2
Release 1.2